One-pot synthesis and antiproliferative activity of novel 2,4-Diaminopyrimidine (cas 156-81-0) derivatives bearing piperidine and piperazine moieties
-
Add time:09/28/2019 Source:infona.pl
A series of novel 2,4-Diaminopyrimidine (cas 156-81-0)s containing piperidine and piperazine moieties were synthesized via an efficient one-pot methodology. The bioassay tests demonstrated that compounds 27 and 28 displayed much stronger antitumor activities against four human cancer cell lines (HepG2, A549, MDA-MB-231 and MCF-7) than positive control fluorouracil. Particularly, compound 28 showed a two-fold improvement compared to fluorouracil in inhibiting MDA-MB-231 and A549 cell proliferation with IC 50 values of 7.46 and 12.78 μM, respectively. Further flow-activated cell sorting analysis revealed that the most promising compound 28 displayed a significant effect on G 2 /M cell-cycle arrest in a dose-dependent manner in MDA-MB-231 cells.
We also recommend Trading Suppliers and Manufacturers of 2,4-Diaminopyrimidine (cas 156-81-0). Pls Click Website Link as below: cas 156-81-0 suppliers
Prev:Crystal Structure of Diethyl[(4chlorophenyl)(dibenzylamino)methyl]propanedioate (cas 156-80-9)
Next:New insights into the structural requirements for pro-apoptotic agents based on 2,4-diaminoquinazoline, 2,4-diaminopyrido[2,3-d]pyrimidine and 2,4-Diaminopyrimidine (cas 156-81-0) derivatives) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- 2,4-Diaminopyrimidine (cas 156-81-0) inhibitors of c-Met kinase bearing benzoxazepine anilines09/30/2019
- New insights into the structural requirements for pro-apoptotic agents based on 2,4-diaminoquinazoline, 2,4-diaminopyrido[2,3-d]pyrimidine and 2,4-Diaminopyrimidine (cas 156-81-0) derivatives09/29/2019